You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.


  • Column: OPEC swamps crude-oil prices
    Crude-oil prices collapsed to a four-year low on Thanksgiving Day, dropping as low as $67.75 per barrel after the Organization of the Petroleum Exporting Countries decided to leave production targets unchanged at its most recent meeting.
  • Who's in charge of Black Friday?
    What about those store managers in charge of making sure merchandise is on the shelves? The Journal Gazette spent some time with a Meijer store director on Friday to get a glimpse into his Black Friday.
  • Oil plunge a panacea for crude-reliant Asia
    A renewed plunge in oil prices is a worrying sign of weakness in the global economy that could shake governments dependent on oil revenues. It is also a panacea as pump prices fall, giving individuals more disposable income and lowering costs for

Equity owners may act to sell stake in Biomet

Biomet Inc.’s private equity owners might be looking to sell their stake in the Warsaw-based orthopedic devices maker, a financial newspaper reported this week.

The Financial Times of London reported Monday that the owners are considering taking the manufacturer public or selling it to another investment group. The publication said it relied on three unnamed sources for the information.

Barbara Goslee, Biomet spokeswoman, said Wednesday that the company doesn’t comment on speculation.

In 2007, a private-equity consortium paid $11.4 billion for Biomet, a transaction the new owners characterize as a merger. The private-equity group includes affiliates of Blackstone Group, Goldman Sachs & Co., Kohlberg Kravis Roberts & Co. and Texas Pacific Group, along with Dane Miller, a Biomet founder and former chief executive.

Miller couldn’t be reached Wednesday for comment.

Brad Bishop, executive director of the nonprofit industry group OrthoWorx, said anyone involved in strategic talks that could lead to a sale would be prohibited from talking publicly about it until a formal announcement was issued.

Biomet employs about 8,000 worldwide, including about 1,500 in Warsaw.

On July 17, 2012, the company reported fiscal 2012 financial results, including a net loss of almost $458 million for the 12 months ended May 31, 2012.

Biomet has not yet released a financial report for fiscal 2013, which ended May 31.